Ar Kay Medicos Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.50 M
as on 16-11-2024
- Company Age 20 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 18.95 Cr
as on 16-11-2024
- Satisfied Charges ₹ 43.18 Cr
as on 16-11-2024
- Revenue 91.11%
(FY 2023)
- Profit 1539.33%
(FY 2023)
- Ebitda 210.86%
(FY 2023)
- Net Worth 37.35%
(FY 2023)
- Total Assets 72.19%
(FY 2023)
About Ar Kay Medicos
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹18.95 Cr. The company has closed loans amounting to ₹43.18 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vivek Khaitan, Pramod Khaitan, and Priya Khaitan serve as directors at the Company.
- CIN/LLPIN
U51397DL2004PTC126490
- Company No.
126490
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 May 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
- Apps
What products or services does Ar Kay Medicos Private Limited offer?
Ar Kay Medicos Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Corona Test Kit.
Who are the key members and board of directors at Ar Kay Medicos?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Khaitan  | Director | 20-May-2004 | Current |
| Pramod Khaitan | Director | 30-Nov-2010 | Current |
| Priya Khaitan | Director | 20-Apr-2018 | Current |
Financial Performance of Ar Kay Medicos.
Ar Kay Medicos Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 91.11% increase. The company also saw a substantial improvement in profitability, with a 1539.33% increase in profit. The company's net worth Soared by an impressive increase of 37.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ar Kay Medicos?
In 2023, Ar Kay Medicos had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Sep 2024 | ₹18.95 Cr | Open |
Standard Chartered Bank Creation Date: 25 Jul 2023 | ₹4.30 M | Satisfied |
Others Creation Date: 09 Mar 2023 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Ar Kay Medicos?
Ar Kay Medicos has a workforce of 18 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ar Kay Medicos, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ar Kay Medicos's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
